Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): past, present, and future implications
Adjuvants, as the name indicates, are adjoined material aimed to assist in functioning as
when added to vaccines they are meant to boost the effect and strongly stimulate the …
when added to vaccines they are meant to boost the effect and strongly stimulate the …
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 …
COVID-19 has caused calamitous health, economic and societal consequences. Although
several COVID-19 vaccines have received full authorization for use, global deployment has …
several COVID-19 vaccines have received full authorization for use, global deployment has …
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for
coronavirus disease of 2019 (COVID-19), has caused havoc around the world. While …
coronavirus disease of 2019 (COVID-19), has caused havoc around the world. While …
Selective IgA deficiency may be an underrecognized risk factor for severe COVID-19
R Ameratunga, E Leung, ST Woon, E Lea… - The Journal of Allergy …, 2023 - Elsevier
SARS-CoV-2, the agent responsible for COVID-19, has wreaked havoc around the globe.
Hundreds of millions of individuals have been infected and well over six million have died …
Hundreds of millions of individuals have been infected and well over six million have died …
Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patients
R Ameratunga, ST Woon, R Steele, K Lehnert… - Journal of Clinical …, 2022 - jcp.bmj.com
After almost 3 years of intense study, the immunological basis of COVID-19 is better
understood. Patients who suffer severe disease have a chaotic, destructive immune …
understood. Patients who suffer severe disease have a chaotic, destructive immune …
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing
R Ameratunga, ST Woon, E Leung, E Lea… - Seminars in Arthritis and …, 2024 - Elsevier
Primary immunodeficiency Disorders (PIDS) are rare, mostly monogenetic conditions which
can present to a number of specialties. Although infections predominate in most PIDs, some …
can present to a number of specialties. Although infections predominate in most PIDs, some …
Effects of SARS-COV-2 infection during the frozen–thawed embryo transfer cycle on embryo implantation and pregnancy outcomes
Y Lu, Y He, Y Wang, Q Zhu, J Qi, X Li… - Human …, 2024 - academic.oup.com
STUDY QUESTION Does severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection during the frozen–thawed embryo transfer (FET) cycle affect embryo implantation …
infection during the frozen–thawed embryo transfer (FET) cycle affect embryo implantation …
Association between COVID-19 vaccines and development of chronic morbidities: a cross-sectional study in the Jordanian population
MI Al-Hawamdeh, R Abu-Huwaij, TA Astiti… - Current Medical …, 2024 - Taylor & Francis
Abstract Background In Jordan, individuals recently diagnosed with chronic illnesses have
expressed concerns with regard to COVID-19 vaccines. This study aims to investigate …
expressed concerns with regard to COVID-19 vaccines. This study aims to investigate …
[HTML][HTML] Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
OBJECTIVES This study investigated the reporting rates of adverse events following
immunization (AEFIs) to the spontaneous reporting system (SRS) and its predictors among …
immunization (AEFIs) to the spontaneous reporting system (SRS) and its predictors among …
Vaccine hesitancy is not increased in patients with ASIA (autoimmune/inflammatory syndrome induced by adjuvants) when compared to patients with vasculitis
JW Cohen Tervaert, C van Eeden, I Butt… - Clinical …, 2023 - Springer
Dear Editor, Mass vaccination campaigns against COVID-19 started in early 2021 and its
efficacy has been clearly demonstrated. Post-vaccine adverse events, however, may occur …
efficacy has been clearly demonstrated. Post-vaccine adverse events, however, may occur …